Wright Medical Group N.V. 4

Accession 0001235802-16-000326

CIK 0001492658operating

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 5:32 PM ET

Size

22.4 KB

Accession

0001235802-16-000326

Form 4

Period: 2016-12-01

Director

Transactions

Sale
Ordinary Shares, par value EUR 0.03 per share
2016-12-01$22.85/sh−29,219$667,566→ 9,783 total
Sale
Ordinary Shares, par value EUR 0.03 per share
2016-12-01$22.79/sh−25,529$581,888→ 39,002 total
Exercise/Conversion
Stock Option (right to buy)
2016-12-01$19.45/sh−7,538$146,614→ 0 total
Exercise: $19.45Exp: 2023-08-09→ Ordinary Shares (7,538 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-12-01$21.66/sh−6,034$130,696→ 0 total
Exercise: $21.66Exp: 2024-08-12→ Ordinary Shares (6,034 underlying)
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2016-12-01$18.04/sh+6,448$116,322→ 45,450 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2016-12-01$19.45/sh+7,538$146,614→ 52,988 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2016-12-01$20.62/sh+5,509$113,596→ 64,531 total
Exercise/Conversion
Stock Option (right to buy)
2016-12-01$18.04/sh−6,448$116,322→ 0 total
Exercise: $18.04Exp: 2022-08-10→ Ordinary Shares (6,448 underlying)
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2016-12-01$21.66/sh+6,034$130,696→ 59,022 total
Exercise/Conversion
Stock Option (right to buy)
2016-12-01$20.62/sh−5,509$113,596→ 5,509 total
Exercise: $20.62Exp: 2025-10-13→ Ordinary Shares (5,509 underlying)

Footnotes (5)

[F1]Includes 6,743 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.6850 to $22.9150 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.7900 to $22.9500 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
[F4]This option has fully vested.
[F5]This option vests in two annual installments, on the one-year and two-year anniversaries of October 13, 2015.

Documents

1 file

Wright Medical Group N.V.

CIK 0001492658

Entity typeoperating

IncorporatedNetherlands